Maravai LifeSciences Holdings, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $524.6M | $315.5M | $551.3M |
| FY2022 | $544.0M | $545.2M | $632.1M |
| FY2023 | $518.7M | $416.8M | $575.0M |
| FY2024 | $517.1M | $434.7M | $573.2M |
| FY2025 | $286.3M | $212.4M | $216.9M |